View Clinical Trial (Medical Research Study)

Assessment of the Cyberlink Control System for Use by the Amyotrophic Lateral Sclerosis (ALS) Patient - NCT00718016-19104(Clinical Trial 231777)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Philadelphia
State:  
PA
Zip Code: 19104
Conditions: Amyotrophic Lateral Sclerosis - Cerebrospinal Fluid - Neurodegenerative Disease - Motor Neuron Disease
Purpose: The goal of this project is to determine whether this device is a practical and realistic means for ALS patients to operate their computers with only the use of facial, brainwave, and eye movements. This study is intended to evaluate both the complexity of the system and the degree to which complications of ALS (such as severity of involuntary movements) may interfere with the use of cyberlink.
Study summary:
Criteria: Inclusion Criteria: - Those aged 18-75 diagnosed with probable or definite ALS. Exclusion Criteria: - Those with decision impairment will not be considered.
Study is available at: MDA/ALS Center of Hope
Philadelphia, PA 19104
United States

Primary Contact:
Christine Barr, RN
Email: cbarr@drexelmed.edu
Phone: 267-507-2585
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 22, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.